دورية أكاديمية

Efficacy evaluation of Shenlan oral liquid in the treatment of experimental thrombosis and hyperlipidemia.

التفاصيل البيبلوغرافية
العنوان: Efficacy evaluation of Shenlan oral liquid in the treatment of experimental thrombosis and hyperlipidemia.
المؤلفون: GU Li-wei, LIU Dan-dan, TIAN Jing-zhuo, ZHANG Hong-bing, ZHAI Xiao-ru, YANG Qian, LI Yong-dong, LI Jin, LI Xin, SHEN Shuo, DU Mao-bo
المصدر: Journal of Hainan Medical University; Apr2023, Vol. 29 Issue 7, p23-29, 7p
مصطلحات موضوعية: ORAL drug administration, HYPERLIPIDEMIA, BLOOD lipids, THROMBOSIS, HIGH density lipoproteins
مستخلص: Objective: To explore the therapeutic effect of Shenlan oral liquid on thrombosis rats and hyperlipidemia mice.Methods: Male Wistar rats were divided into four groups randomly: the control group,the Shenlan oral liquid groups ( high dosage and low dosage),and the positive control group. Rats in the control group were treated with dd water intragastriclly; in the positive control group, rats were treated intragastric with aspirin. Rats were treated with different drugs intragastric for continuous 22 d. In the hyperlipidemia experiment, mice were fed with high-fat diet to induce hyperlipidemia model mice, then randomly divided into five groups; the control group,the model group, the atorvastatin calcium positive control group,and the Shenlan oral liquid groups ( high dosage and low dosage). The serum lipid and body weight changes of mice were observed after 6 weeks.Animals in Shenlan oral liquid high and low dosage were treated intragastric with six times and double the clinical dose. Results: After treatment, the mix blocking rate and average blocking rate of the vascular after electrical stimulation were obviously reduced in aspirin group, and Shenlan oral liquid high and low dose groups(P<0.05 or P<0.01). The maximum aggregation rate was significantly lower than that of control group (P<0.05 or P<0.01), and the normal coagulation function was not affected. In the treatment of hyperlipidemia, the effects of Shenlan oral liquid were measured on the total cholesterol (TC), triacylglycerol (total triglyceride, TG), low density lipoprotein (LDL-C) and high-density lipoprotein (HDL-C) with the hyperlipidemia mice. After 2 weeks administration,the serum TG level of Shenlan oral liquid high-dose group decreased compared with the model group. The TG level of serum in Shenlan oral liquid high-dose group significantly decreased compared with the model group from the fourth week (P<0.05). After 6 weeks administration, Shenlan oral liquid high-dose and low-dose group and positive drugs reached to the same therapeutic effect. Compared with model group, serum TG level was significantly decreased (P<0.05 or P<0.01). Conclusion: Shenlan oral liquid can decrease the thrombosis formation in rats and inhibit the lipid level in blood in hyperlipidemia mice. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Hainan Medical University is the property of Journal of Hainan Medical College Editorial Office and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index